Prosecution Insights
Last updated: April 19, 2026

Everfront Biotech Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18270071 USE OF PHTHALIDE COMPOUNDS IN TREATMENT OF MENINGIOMA WHITE, DAWANNA SHAR-DAY 1627 Non-Final OA Jun 28, 2023
17792468 COMBINATION FOR THE TREATMENT OF CANCER AND APPLICATION THEREOF ROBINSON, MIKHAIL O'DONNEL 1627 Non-Final OA Sep 07, 2022

Managing Everfront Biotech Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month